Back

Results - Announcements

Sales rise 6.06% to Rs 966.08 crore

Glaxosmithkline Pharmaceuticals standalone net profit rises 34.73% in the March 2025 quarter

14-May-2025, 07:27
Net profit of Glaxosmithkline Pharmaceuticals rose 34.73% to Rs 260.14 crore in the quarter ended March 2025 as against Rs 193.08 crore during the previous quarter ended March 2024. Sales rose 6.06% to Rs 966.08 crore in the quarter ended March 2025 as against Rs 910.87 crore during the previous quarter ended March 2024.

For the full year,net profit rose 57.19% to Rs 919.06 crore in the year ended March 2025 as against Rs 584.69 crore during the previous year ended March 2024. Sales rose 9.28% to Rs 3723.49 crore in the year ended March 2025 as against Rs 3407.25 crore during the previous year ended March 2024.

Particulars	Quarter Ended			Year Ended
	Mar. 2025	Mar. 2024	% Var.	Mar. 2025	Mar. 2024	% Var.
Sales	966.08	910.87	6	3723.49	3407.25	9
OPM %	34.24	28.03	-	31.40	26.43	-
PBDT	369.62	284.41	30	1310.54	1022.33	28
PBT	354.90	266.31	33	1243.75	952.65	31
NP	260.14	193.08	35	919.06	584.69	57